Proteotype Diagnostics Selected for EU-Funded HER-CARE Doctoral Network, Signalling Growing Research Leadership in Precision Oncology

CAMBRIDGE, England, April 27, 2026 /PRNewswire/ -- Proteotype Diagnostics Ltd announced its selection as an industrial beneficiary in the HER-CARE Marie Skłodowska-Curie Doctoral Network (MSCA-DN), a European research initiative focused on improving outcomes for patients with hereditary...